Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18693161rdf:typepubmed:Citationlld:pubmed
pubmed-article:18693161lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C0033551lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18693161lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:18693161pubmed:issue5lld:pubmed
pubmed-article:18693161pubmed:dateCreated2008-9-9lld:pubmed
pubmed-article:18693161pubmed:abstractTextHypersensitivity to cyclooxygenase (COX) inhibitors is rare in children. We studied 164 children reporting 213 reactions to paracetamol, ibuprofen and/or acetylsalicylic acid (ASA). Most reactions were cutaneous, either isolated or associated with respiratory symptoms and/or anaphylaxis. Based on a convincing clinical history or positive responses in challenges with the drug(s), hypersensitivity to one or several drug(s) was diagnosed in 49.4% of the children (60, 76.5 and 23.2% of the children reporting reactions to ASA, ibuprofen and paracetamol respectively). Cross-reactivity between nonsteroidal anti-inflammatory drugs (NSAIDs) was frequent (69.1%), but only 10.6% of the NSAID-sensitive children reacted to paracetamol. In contrast, all paracetamol-sensitive children reacted to NSAIDs. Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for hypersensitivity and/or cross-reactivity between ASA, ibuprofen and paracetamol. In conclusion, hypersensitivity to COX inhibitors was frequent, especially in children reporting severe and/or immediate and accelerated reactions, and in older and atopic children. Cross-reactivity was frequent, suggesting that most reactions resulted from a non allergic hypersensitivity linked to the pharmacological properties of the drugs. However, in a few children, the reactions may result from allergic hypersensitivity to selective (families of) drugs, with tolerance to other drugs.lld:pubmed
pubmed-article:18693161pubmed:languageenglld:pubmed
pubmed-article:18693161pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18693161pubmed:citationSubsetIMlld:pubmed
pubmed-article:18693161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18693161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18693161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18693161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18693161pubmed:statusMEDLINElld:pubmed
pubmed-article:18693161pubmed:issn1167-1122lld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:Le...lld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:ScheinmannPie...lld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:PonvertClaude...lld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:HassaniAmaleAlld:pubmed
pubmed-article:18693161pubmed:authorpubmed-author:KarilaChantal...lld:pubmed
pubmed-article:18693161pubmed:issnTypePrintlld:pubmed
pubmed-article:18693161pubmed:volume18lld:pubmed
pubmed-article:18693161pubmed:ownerNLMlld:pubmed
pubmed-article:18693161pubmed:authorsCompleteYlld:pubmed
pubmed-article:18693161pubmed:pagination561-5lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:meshHeadingpubmed-meshheading:18693161...lld:pubmed
pubmed-article:18693161pubmed:articleTitleHypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases.lld:pubmed
pubmed-article:18693161pubmed:affiliationPediatric Service, Military Hospital Mohamed V, Rabat-Salé, Morocco.lld:pubmed
pubmed-article:18693161pubmed:publicationTypeJournal Articlelld:pubmed